Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents.

ABSTRACT:

SUBMITTER: Hammond D 

PROVIDER: S-EPMC10514257 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature